Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process

Provided By Globe Newswire

Last update: Nov 14, 2022

Diffusion in Active Bidding Stage and Encouraged by Response to the Strategic Review Process

Diffusion Board of Directors Rejects Woefully Inadequate, Unsolicited Offer for the Company by client of Investment Bank LifeSci Capital